You just read:

UPDATE: To Acquire Sinovac Biotech (Nasnaq: SVA) Sinobioway Consortium Raises Its Purchase Price To $8 Per Share

News provided by

Shandong Sinobioway Biomedicine Co., Ltd

Jun 30, 2017, 14:43 ET